IS UNIVERSAL SCREENING OF INDIVIDUALS FOR HBV, HCV AND HIV BEFORE ENDOSCOPY JUSTIFIED? AN AUDIT OF THE CURRENT PRACTICES
Keywords:
Endoscopy, Endodisinfector, AuditAbstract
Objective: To find out the current practices of sterilization and decontamination of endoscopy equipment, and to
compare them with the current practical guidelines in rest of the world.
Material and Methods: This was a retrospective study carried out from January 2014 to December 2014 in the Departments
of Medicine HMC, KTH, Peshawar. All the patients scheduled for endoscopy are screened for any evidence of
Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) by third generation ELISA
test. The approximate cost of these screening tests from the hospital main laboratory is Rs 650 and it is between Rs
900 to 3000 from the outside private laboratory facilities. The endoscope is soaked in a decontaminant solution for
30 mins in the morning before the start of the procedures. The endoscope is the washed with water and air dried. In
between the procedures, the endoscope is wiped cleaned with a gauze piece soaked in saline and then introduced
in another patient.
Results: As all the patients are screened for any evidence of HBV, HCV and HIV, it is presumed that the iatrogenic
infection due to endoscope would be negligible. Universal screening for the evidence of these infections comes at
average Rs 1000 per patient as compared to Rs 35 for the endoscope cleaning with the cleansing and rinsing of all the
channels of the endoscope with 2% glutaraldehyde solution (Cidex, Johnson and Johnson Medical Inc., Arlington, TX)
for 15 minutes through automated Endodisinfector followed by rinsing the channels with water and later purging with air.
Conclusion: Timely intervention in terms of Endodisinfection and appropriate training of the staff in sterilization and
disinfection of the endoscopes as per international guidelines is suggested before it becomes a human rights issue.
Downloads
Published
How to Cite
Issue
Section
License
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.